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Health care professionals have an opportunity to
play a key role in reducing allergy risk. This
supplement outlines the problem of allergic
disease. It also gives strategies to help identify
which children or families may be at greatest risk
of allergy, and how to deal with these issues.
Current and projected allergy incidence
The incidence of allergic disease has trebled over the
last 20 years. Now 12 million people need treatment
for allergic disease every year. Allergic disease affects
one in three people in the UK.
Up to 357o of children in industrialized areas are
reported to be affected by allergy, and approximately
60% of allergies appear during the first year of life.
Paediatric allergy is a growing problem, but what
people don't realise is that any infant could develop
an allergic disease. In particula4, food allergy is one of
the most common forms of allergy in infants. A recent
study on the Isle of Wight (Pereira ef al.) confirmed
that 2.3% o{ 11- and 15-year-old chiidrery and 6.5%
of 1-3-year-olds, have food hypersensitivity.
Tieatment of diseases such as food allergy, eczema,
rhinitis and asthma places a particularly intense
burden on the NHS because of the increasing pre-
valence, severity and complexity of these conditions.
We need to identify, and use, prevention measures
so that the burden of allergy can be lessened.
Describing allergy and sensitivity correctly
First, it's important to clarify the prevention strategies
that health care professionals can follow. Primary
allergy prevention describes measures that are taken
to prevent sensitisation. In other words, following a
strategy to stop an infant's immune system from
producing immunoglobulin (Ig)E in response to a
particular protein.
Secondary allergy prevention describes measures
taken to stop the already sensitised, asymptomatic
individuai from becoming clinically allergic. This
includes preventing further allergic disease in an
infant who is already sensitised to a specific allergen
(e.g. pollery dust mite).
Therefore, prevention of allergic disease does not
include treatment of infants already clinically allergic,
such as those suffering from food allergy, asthma,
eczema or rhinitis/hayfever.
Cows' milk is usually the first source of foreign
antigen encountered in infancy, either through dairy
foods eaten by the breast-feeding mother, infant
formula or weaning foods. Around 50% of infants with
atopic dermatitis or food sensitizations will eventually
develop respiratory diseases (Figure 1). This process
is referred to as the atopic march.
In order to prevent allergic disease, especially
food allergy, the correct nomenclature and definitions
should be used.
A European Academy of Allergy and Clinical
lmmunology task force (johansson SG et aL) suggested
that any adverse reactions to food should be called
f ood hypersensitivity. When immunological mecha-
nisms have been demonstrated, they suggest that the
appropriate term is food allergy. Where the role of
IgE is confirmed, they suggest that it is known as
IgE-mediated food allergy. The task force also
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Figure 1: An
interpretation of
the allergic march.
Around half of all
babies with atopic
dermatitis or food
sensitizations will
go on to develop
respiratory
diseases.
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